A Pilot Study Evaluating Time to CD4 T-cell Count <350 cells/mm3 After Treatment Interruption Following Antiretroviral Therapy ± Interleukin 2: Results of ACTG A5102 (Q56101132)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | A Pilot Study Evaluating Time to CD4 T-cell Count <350 cells/mm3 After Treatment Interruption Following Antiretroviral Therapy ± Interleukin 2: Results of ACTG A5102 |
article |
Statements
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102 (English)
Keith Henry
David Katzenstein
Deborah Weng Cherng
Hernan Valdez
Michelle Blanchard Vargas
Mark Winters
Nasreen C Jahed
Jeffrey M Jacobson
Laurie S Myers
John L Schmitz
A5102 Study Team of the AIDS Clinical Trials Group